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Assessment of immune responses in healthy adults following dietary or lifestyle inter-
ventions is challenging due to significant inter-individual variability. Thus, gaining a better
understanding of host factors that contribute to the heterogeneity in immunity is necessary.
To address this question, healthy adults [n=36, 18–40 years old, body mass index (BMI)
20–35 kg/m2] were recruited. Dietary intake was obtained via 3-day dietary recall records,
physical activity level was evaluated using the International Physical Activity Questionnaire,
and peripheral blood mononuclear cells were isolated from peripheral blood. Expression
of activation markers on unstimulated immune subsets was assessed by flow cytome-
try. T-cell proliferation and cytokine secretion was assessed following in vitro stimulation
with anti-CD3 or lipopolysaccharide. Furthermore, the incidence and severity of cold or
flu symptoms were obtained from self-reported upper respiratory tract infection (URTI)
questionnaires.The relationship between activation marker expression onT cells andT-cell
effector functions; and in vitro cytokine secretion and URTI was determined by linear or
logistic regression. CD69 and CD25 expression on unstimulated T cells was significantly
associated with T-cell proliferation and interleukin-2 secretion. Incidence and severity of
cold or flu symptoms was significantly associated with in vitro interleukin-6 and interferon-
gamma secretion, respectively. Furthermore, host factors (e.g., age, BMI, physical activity,
and diet) contributed significantly to the relationship between activation marker expression
and T-cell effector function, and cytokine secretion and cold and flu status. In conclusion,
these results suggest that lifestyle and dietary factors are important variables that con-
tribute to immune responses and should be included in human clinical trials that assess
immune endpoints.
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INTRODUCTION
Host immune function is influenced by endogenous factors (e.g.,
age, gender, genetics), as well as various exogenous factors (e.g.,
diet, physical activity, alcohol consumption) (1–6). Thus, hetero-
geneity in both innate and adaptive immune responses exists even
among healthy adults. This inter-subject variability makes it chal-
lenging to evaluate the effect of dietary or lifestyle interventions on
immune function as many of these interventions have moderate
Abbreviations: BMI, body mass index; Con A, concanavalin A; DCs, dendritic cells;
HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; IFN-
γ, interferon-gamma; IL-2, interleukin-2; IL-6, interleukin-6; IPAQ, International
Physical Activity Questionnaires; LDL, low-density lipoprotein; LPS, lipopolysac-
charide; MET, metabolic equivalent of task; MFI, mean fluorescence intensity; n-3
PUFA, n-3 polyunsaturated fatty acids; OR, odds ratio; PBMC, peripheral blood
mononuclear cells; PHA, phytohemagglutinin; PMA, phorbol myristate acetate;
SEB, staphylococcal enterotoxin; SI, stimulation index; TC, total cholesterol; TG,
triglycerides; TNF-α, tumor necrosis factor-alpha; TT, tetanus toxoid; URTI, upper
respiratory tract infection.
effects as compared to pharmacological intervention trials (5, 7).
Additionally, cost and feasibility often limit the sample size in clin-
ical trials. Thus, gaining a better understanding of host-related
factors that may contribute to the variability in innate and adap-
tive immune responses in healthy adults is necessary to adequately
control for the contribution of these influences in clinical trials
that assess immunity.
The assessment of innate and adaptive immune function often
involves complex assay methodologies; thus large clinical trials fre-
quently are not designed to quantify these types of immunologic
outcomes. Many human clinical trials measure serum makers (e.g.,
antibody titers, cytokine levels) as indicators of immune func-
tion because of ease of collection, assessment, and storage (5).
However, these endpoints alone may not adequately capture the
immune response. Thus, additional studies are needed to assess
functional immune outcomes (e.g., T-cell proliferation, in vitro
cytokine secretion) concurrently with the phenotypic characteri-
zation of immune cell populations via flow cytometry to determine
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if cell surface marker expression on immune cells can serve as a
biomarker for effector function (e.g., proliferation and cytokine
secretion).
Numerous human clinical trials have evaluated the effect of
lifestyle interventions on the incidence and severity of cold or flu
symptoms captured in self-reported upper respiratory tract infec-
tion (URTI) questionnaire data. The immune response of the host
is known to be an important component of the pathogenesis of
cold or flu infection (8). However, very few studies have quanti-
fied immune function (inflammatory cytokine responses or T-cell
function) concurrently with the self-reported URTI questionnaire
data to determine if any immune outcomes are correlated with
cold or flu symptomology. Two studies have reported an increase
in salivary IgA concentration in subjects who had a lower inci-
dence and severity of URTI symptoms (9, 10). In a third study, the
risk of URTI in athletes was associated with antigen-stimulated
interleukin (IL)-10 production and salivary IgA secretion (11).
All three studies demonstrate that changes in immune function
can be correlated with reduced symptoms of URTI. However, the
goal of these studies was to determine if exercise reduced URTI,
so the relationship between URTI symptomology, salivary IgA,
and IL-10 may be confounded by the exercise intervention. To
date, no studies have examined inflammatory cytokine response
or T-cell effector function in subjects who completed self-reported
URTI questionnaire data to determine if T-cell effector function or
inflammatory cytokine production was related to URTI incidence
or severity.
Therefore, the goals of the current study were (1) to determine
which endogenous and exogenous host factors contribute to the
heterogeneity in innate and adaptive immune responses among
healthy subjects; (2) to determine if activation marker expression
on freshly isolated T cells, macrophages, or dendritic cells (DCs) is
associated with functional outcomes, i.e., anti-CD3-induced T-cell
proliferation and cytokine [IL-2 and interferon-gamma (IFN-
γ)] secretion or lipopolysaccharides (LPS)-stimulated cytokine
[tumor necrosis factor-alpha (TNF-α) and IL-6] secretion from
peripheral blood mononuclear cells (PBMCs), respectively; and
(3) to determine if T-cell proliferation and/or in vitro inflamma-
tory cytokine production is associated with self-reported incidence
and severity of cold or flu symptoms collected using a validated
URTI questionnaire.
MATERIALS AND METHODS
PARTICIPANTS
Healthy subjects (n= 36, 25 women and 11 men) 18–40 years of
age were recruited for the study. Exclusion criteria included: body
mass index (BMI) greater than 40 kg/m2, smoking and/or use
of other tobacco products, blood pressure ≥140/90 mm Hg, use
of blood pressure- or cholesterol-lowering medications, history
of myocardial infarction, stroke, diabetes mellitus, liver disease,
kidney disease and thyroid disease (unless controlled by med-
ication and blood results within the previous 6 months were
provided), lactation, pregnancy or desire to become pregnant
during the study, clinical diagnosis of inflammatory bowel dis-
ease (e.g., Crohn’s disease or ulcerative colitis), excessive alco-
hol consumption (>14 standard drinks/week), chronic use of
anti-inflammatory medications (unless able to discontinue), and
refusal to agree to give blood or plasma for the length of the
study. A complete blood count and standard biochemistry panel
was obtained at screening to rule out the presence of illness
(autoimmune disease, cancer, and immunodeficiency). Blood
pressure was measured according to the Joint National Committee
7 Guidelines (12).
RECRUITMENT AND SCREENING
Participants were recruited through advertisements in the local
newspaper and university e-mail lists. Potential participants who
called or emailed to indicate interest in participating in the study
were given information about the study, and if still interested,
were contacted and screened using a series of medical and lifestyle
questions. Qualified participants were scheduled for clinic screen-
ing at the Penn State Clinical Research Center (CRC). After written
informed consent was provided, participants’ height, weight, waist
circumference, and blood pressure were measured, followed by a
fasting blood draw for a complete blood count and metabolic
and immunologic endpoints. BMI was calculated according to
body weight and height measured. From the participants who
were screened, 36 were eligible to participant in the study. All
the experiments in this study were performed with approval
of the Institutional Review Board of the Pennsylvania State
University-University Park campus (University Park, PA, USA).
DIET ASSESSMENT
Dietary intake of the participants was obtained via 24 h dietary
recalls for three continuous days. Briefly, participants were asked
to recall their intake of food and beverages during breakfast,
lunch, dinner, and snacks in the three continuous days accord-
ing to detailed instructions provided by trained staff. Portion size
of each food item was also provided. Daily intake of total calo-
ries, macronutrients, vitamins, minerals, caffeine, and alcohol was
analyzed based on the recorded food intake of participants using
Food Processor SQL software (ESHA Research, Salem, OR, USA).
PHYSICAL ACTIVITY ASSESSMENT
Physical activity level of participants was evaluated using the
International Physical Activity Questionnaires (IPAQ) as previ-
ously reported (13). Briefly, the participants recorded the activities
they performed during each 15-min interval for 3 days, includ-
ing one weekend day. The activities were categorized from one to
nine depending on their intensity as previously described (13).
Daily intensity of physical activity was calculated by averaging
the approximate metabolic equivalent of tasks (METs) of physical
activities (categories three to nine) performed over a 24-h period
(96 periods of 15 min).
UPPER RESPIRATORY TRACT INFECTION QUESTIONNAIRE
Participants (n= 34) completed a self-administered URTI ques-
tionnaire, which was developed from established, frequently used
instruments on the incidence (whether or not have experienced
colds or flu episodes, with symptoms including a sore throat, runny
or stuffy nose, coughing sneezing, fever, headache, general aches
and pains, fatigue, and discomfort) and severity (total number of
days with cold or flu symptoms) of cold or flu symptoms over the
past month. Participants were instructed to recall the occurrence
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of cold or flu in the last month, and advised on questionnaire
completion. Two participants did not provide any information in
their URTI questionnaires for unknown reasons.
BLOOD SAMPLE COLLECTION AND IMMUNOLOGICAL ASSAYS
Blood (50 ml) was collected in sterile EDTA (K2)-coated blood
tubes (BD Biosciences, San Jose, CA, USA) after a 12-h fast by
trained staff in CRC of Pennsylvania State University.
Serum markers
Total cholesterol (TC) and triglycerides (TG) were measured by
enzymatic procedures (Quest Diagnostics, Pittsburgh, PA, USA;
coefficient of variation CV<2% for both). High-density lipopro-
tein (HDL) cholesterol was estimated according to the modi-
fied heparin–manganese procedure (CV <2%). The Friedewald
equation was used to calculate low-density lipoprotein (LDL)
cholesterol=TC− (HDL cholesterol+TG/5) (14). Insulin was
measured by radioimmunoassay (Quest Diagnostics). Glucose was
determined by an immobilized enzyme biosensor using the YSI
2300 STAT Plus Glucose and Lactate Analyzer (Yellow Springs
Instruments). Serum high-sensitivity C-reactive protein (hs-CRP)
was measured by latex-enhanced immunonephelometry (Quest
Diagnostics; assay CV<8%).
Isolation of immune cells
Human blood was diluted 1:2 with phosphate buffer saline (PBS;
Mediatech, Manassas, VA, USA), gently layered on top of lympho-
cyte separation media (LSM; Corning, Manassas, VA, USA), and
centrifuged at 1600 rpm with low speed and no brake for 30 min
at room temperature. PBMCs were collected at the plasma/LSM
interface; washed twice with complete media RPMI 1640 (Mediat-
ech) containing 10 mM HEPES (Mediatech), 10% heat-inactivated
fetal bovine serum (Gemini, West Sacramento, CA, USA), 2 mM
L-glutamine (Mediatech), 0.1 mM non-essential amino acids
(Mediatech), 1 mM sodium pyruvate (Mediatech), 100 U/ml peni-
cillin/streptomycin (Mediatech), and 55µM 2-mercaptoethanol
(Life Technologies, Grand Island, NY, USA) at room temperature;
and counted for use in functional and phenotypic analyses.
Lymphocyte proliferation assay
Peripheral blood mononuclear cells (2× 106/ml) were incubated
with 0 or 1µg/ml plate-bound purified mouse anti-human CD3
antibody (Life Technologies) in flat-bottomed 96-well plates.
After 54 h in culture, the cells were pulsed with [3H] thymidine
(1µCi/well; Perkin-Elmer, Waltham, MA, USA) and harvested
18 h later. Following incubation, cells were harvested onto glass
fiber filter mats (Perkin-Elmer) via a MicroBeta FilterMate-96
Harvester (Perkin-Elmer). Incorporated radioactivity was mea-
sured by liquid scintillation counting on a 2450 MicroBeta plate
counter (Perkin-Elmer). Each assay was performed in triplicate.
The proliferative response was expressed as a stimulation index
(SI) calculated by dividing the mean counts per minute (cpm)
of anti-CD3-stimulated T cells by the mean cpm of unstimulated
(media only) cells.
Cytokine secretion assays
Peripheral blood mononuclear cells (2× 106/ml) were stimu-
lated with 1µg/ml plate-bound purified mouse anti-human CD3
antibody (Life Technologies), or 10µg/ml LPS (Sigma-Aldrich) in
flat-bottomed 96-well plates. Supernatants from LPS plates were
harvested and frozen after a 4-h incubation, and supernatants from
anti-CD3 plates were harvested and frozen after 48 h. IFN-γ and
IL-2 secretion from anti-CD3-stimulated PBMCs, and TNF-α and
IL-6 secretion from LPS-stimulated PBMCs were measured using
the Human ELISA MAX™ Deluxe (BioLegend, San Diego, CA,
USA) as per manufacturer instructions. Each assay was performed
in triplicate.
Flow cytometric analyses
Peripheral blood mononuclear cells were washed twice in PBS at
4°C. Fc receptors on PBMCs were blocked by incubation with 1µg
purified mouse anti-human CD16 (BioLegend)/1× 106 cells for
15 min at 4°C. PBMCs were stained with fluorescence-labeled anti-
bodies (1µg/1× 106 cells) to the following cell surface markers:
CD3e, CD4, CD8a, CD69, CD25, CD11c, CD14, HLA-DR. Anti-
body isotype controls included: mouse IgG2a and mouse IgM.
All antibodies except CD16 were purchased from BD Biosciences.
Following incubation with the conjugated antibodies for 30 min at
4°C, cells were washed twice in PBS and then fixed in cytofix (BD
Biosciences) for flow cytometric analyses. Lymphoid and myeloid
cells were gated on forward vs. side scatter and a total of 25,000
events were analyzed on a FC500 Benchtop Cytometer (Beckman
Coulter, Pasadena, CA, USA). Flow cytometric analyses were plot-
ted and analyzed using FlowJo 7.6 (Tree Star, Ashland, OR, USA).
STATISTICAL ANALYSES
Spearman’s rank correlation was used to determine the rela-
tionship between IL-2 and IFN-γ secretion from T cells and
T-cell proliferation. Differences in IFN-γ secretion from anti-
CD3-stimulated T cells between participants with and without
self-reported cold or flu episodes in the past month were deter-
mined using unpaired t -test. Differences in IL-6 secretion from
LPS-stimulated PBMCs between participants with and without
self-reported cold or flu episodes in the past month were deter-
mined using Wilcoxon–Mann–Whitney test. Correlations between
LPS-induced IL-6 secretion and anti-CD3-induced IFN-γ secre-
tion and total number of days with cold or flu symptoms was
determined via Spearman’s rank correlation.
For all linear, logistic, and Poisson regression models, potential
confounders (listed in Tables 3 and 4) were selected based on pre-
vious published reports demonstrating a relationship between the
variable of interest (e.g., BMI, vitamin D, zinc, etc.) and immune
outcomes (2, 3, 6, 15–31). Confounding variables varied in dif-
ferent models, and were selected in each model based on their
ability to change the slope of the regression line for the predic-
tor. Briefly, a full model was fitted with either effector function or
incidence and severity of cold or flu infection as the dependent
variable and activation marker expression and all potential con-
founding factors mentioned above as the independent variables
(predictors). Then, the potential confounding factor showing the
smallest contribution to the model was removed, and the percent
change of β for predictor in the current model relative to β in the
full model was calculated. If the change was within ±10%, this
potential confounding factor was deleted from the model. The
potential confounding factors were removed from the model one
by one based on the 10% change criteria until all the variables
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remaining in the model were significant at p≤ 0.05 level or the
percent change of β was beyond ±10% range. Automated back-
ward and stepwise elimination were also performed to determine
which variables remained in the final model. Similar findings were
obtained using all three model-building techniques.
Statistical significance was accepted at the p≤ 0.05 level. All
data were analyzed using Statistical Analysis System (SAS, Version
9.4, Cary, NC, USA). Graphs were plotted using GraphPad Prism
5 (La Jolla, CA, USA).
RESULTS
PARTICIPANT CHARACTERISTICS
Anthropometric measurements, blood pressure, biochemical
characteristics, physical activity, and dietary intake of partici-
pants are presented in Table 1. All 36 participants (25 females
and 11 males) completed the study. The participants were healthy,
young adults (mean age of 28.3± 1.0 years). The average BMI was
24.0± 0.4 kg/m2; 26 (72.2%) participants were normal weight, 9
(25.0%) were overweight, and 1 (2.8%) was obese. Their blood
pressure was normal and waist circumference, fasting blood glu-
cose, insulin, lipids and lipoproteins, and CRP levels were within
the normal range (Table 1). Dietary intake and physical activ-
ity was assessed from self-reported 3-day dietary recall records
and IPAQ responses, respectively. The median daily physical activ-
ity intensity (based on self-reported responses) was estimated
to be 3.1 METs (range 2.4–5.2 METs). The average daily total
calorie intake of participants calculated from 3-day dietary recall
records was estimated to be 2281.0± 130.8 kcal. The daily intake of
macronutrients, vitamins, minerals and n-3 polyunsaturated fatty
acids (n-3 PUFA), caffeine, and alcohol are reported in Table 1.
T-CELL PROLIFERATION AND CYTOKINE SECRETION
T-cell proliferation (Figure 1A), IL-2 (Figure 1B), and IFN-γ
(Figure 1C) secretion in response to 1µg/ml anti-CD3 antibody
stimulation were measured to determine the effector function of
T cells from participants. The mean T-cell proliferation (reported
as SI) in response to anti-CD3 antibody was 149.40± 19.52
(range 15.04–511.80). The mean IL-2 and IFN-γ production from
anti-CD3-stimulated T cells was 0.37± 0.08 ng/ml (range 0.00–
1.45 ng/ml) and 102.70± 8.09 ng/ml (range 1.35–169.40 ng/ml),
respectively. We observed a large variation in all T-cell effec-
tor functions (proliferation and cytokine secretion). Therefore,
the relationship between T-cell proliferation and cytokine secre-
tion was examined to determine if subjects with greater T-cell
proliferation were those with high IL-2 and IFN-γ production.
T-cell proliferation was significantly correlated with IL-2 secre-
tion (Figure 1D; Spearman r = 0.3751, p= 0.0264), but not with
IFN-γ secretion (Figure 1E; Spearman r = 0.0689, p= 0.6941).
ACTIVATION MARKER EXPRESSION ON UNSTIMULATED T CELLS
The percentage of CD3+CD69+ (Figure 2A) and CD3+CD25+
(Figure 2B) cells, and the mean fluorescence intensity (MFI) of
CD69 and CD25 on double positive cells (Figures 2C,D, respec-
tively) were quantified to determine the activation status of freshly
isolated T cells. Bivariate plots of CD3 vs. CD69 expression are
shown from one representative subject in Figures 2A,B inset
graphs, respectively. The mean percentage of CD3+CD69+ T cells
Table 1 | Demographic characteristics of participantsa.
Characteristics Values (n=36)
Age (year) 28.3±1.0
Male, n (%) 11 (30.6%)
Body mass index (kg/m2) 24.0±0.4
≤24.9 26 (72.2%)
25.0–29.9 9 (25.0%)
≥30 1 (2.78%)
Waist circumference (cm) 85.2±1.3
Blood pressure (mm Hg)
Systolic 106.3±1.6
Diastolic 72.6±1.1
Glucose (mg/dl) 87.4±1.2
Insulin (mg/dl) 5.2±0.7
CRP (mg/l) 2.5±0.9
Lipids and lipoproteins (mg/dl)
Total cholesterol (TC) 164.7±4.8
LDL cholesterol 92.6±4.3
HDL cholesterol 54.9±1.9
Triglyceride (TG) 85.8±4.8
Physical activity intensity (METs/d)b 3.1 (2.4–5.2)
Dietary intakeb of
Total calories (kcal/day) 2281.0±130.8
Carbohydrate (g/day) 281.1±17.7
Protein (g/day) 88.4±6.1
Fat (g/day) 90.2±6.0
Vitamin C (mg/day) 69.5±10.7
Vitamin D (IU/day) 106.1±29.3
Vitamin E (mg/day) 3.1±0.5
Iron (mg/day) 14.3±1.2
Selenium (µg/day) 40.2±4.4
Zinc (mg/day) 6.0±0.6
n-3 PUFA (g/day) 0.6±0.1
Caffeine (mg/day) 71.3±14.6
Alcohol consumption (g/day) 2.2±0.9
aValues are presented as mean±SEM, or median (range) or n (%) depending on
the variable.
bPhysical activity and dietary intake were assessed from self-reported responses
to IPAQ and 3-day dietary recall records, respectively.
in PBMCs was 9.74± 1.87% (range 0.03–41.92%, Figure 2A),
and the mean percentage of CD3+CD25+ T cells in PBMCs
was 8.97± 1.24% (range 0.92–36.39%, Figure 2B). The MFI of
CD69 on CD3+CD69+ T cells was 13,119± 1878 (range 2546–
39,050), and the average MFI of CD25 on CD3+CD25+ T cells
was 15,791± 2267 (range 4504–60,450). Representative flow his-
tograms of CD69 expression on CD3+CD69+ cells and CD25
expression on CD3+CD25+ cells are shown in Figures 2C,D inset
graphs, respectively.
ACTIVATION MARKER EXPRESSION ON UNSTIMULATED T CELLS WAS
ASSOCIATED WITH T-CELL PROLIFERATION AND CYTOKINE SECRETION
To determine if activation marker expression (CD69 and CD25
expression) on freshly isolated, unstimulated T cells and T-cell
subsets, and other host factors (e.g., age, BMI, physical activity,
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FIGURE 1 | Effector function ofT cells. Proliferation of T cells (A) in
response to anti-CD3 antibody was assessed by tritiated thymidine
[3H] incorporation. Stimulation index (SI) was calculated by dividing
the mean cpm of stimulated T cells (in response to 1µg/ml
anti-CD3) by the mean cpm of unstimulated cells (in media alone).
Anti-CD3-stimulated IL-2 (B) and IFN-γ (C) secretion from T cells was
measured by ELISA. Data are presented as mean±SEM. T-cell
proliferation was significantly correlated with IL-2 secretion
[(D); Spearman r =0.3751, p= 0.0264], but not with IFN-γ secretion
[(E); Spearman r =0.0689, p=0.6941].
and dietary factors) contribute to the variation in effector func-
tion (e.g., T-cell proliferation and IL-2 and IFN-γ secretion), linear
regression analysis was used. Most of the variables in Table 1
contributed less than 10% to any of the immune outcomes (T-
cell proliferation and IL-2 and IFN-γ secretion) when included
in the model alone (without activation marker expression), with
the exception of age, HDL, and vitamin D which contributed
10.3, 11.0, and 11.3% of the variability in IL-2 secretion (Table 2;
R2= 10.25; 10.98; and 11.27%, respectively). Also, hs-CRP and vit-
amin D contributed to 11.6 and 12.1% of the variability in IFN-γ
secretion (Table 2; R2= 11.55 and 12.13%, respectively). How-
ever, the MFI of CD69 on CD3+CD69+ T cells alone accounted
for 29% of the variability in T-cell proliferation (Table 3, model 1,
β= 0.0058, R2= 29.17%, p= 0.0008). When BMI and the MFI of
CD69 on unstimulated CD3+CD69+ T cells were included in the
model, 45% of the variability in T-cell proliferation was explained
(Table 3, model 2, β= 0.0063, R2= 44.95%, p< 0.0001). The MFI
of CD25 on unstimulated CD3+CD25+ T cells was also signifi-
cantly associated with T-cell proliferation. The MFI of CD25 on
CD3+CD25+ T cells alone accounted for 16% of the variability in
T-cell proliferation (Table 3, model 1, β= 0.0035, R2= 15.78%,
p= 0.0181). However, the predicted value of CD25 MFI on
unstimulated CD3+CD25+ T cells was no longer significant when
physical activity, daily intake of vitamin D, selenium, and n-3
PUFA were included in the model (Table 3, model 2, β= 0.0021,
R2= 36.29%, p= 0.1490). Similar analyses were conducted to
explore the relationship between the MFI of CD69 and CD25
on unstimulated T-cell subsets and T-cell proliferation. Data are
presented in Tables S1 and S2 in Supplementary Material. The R2
of the predictor (activation marker expression) plus the individual
confounding variables included in the models described in Table 3
were examined to compare the relative contribution of each con-
founding variable when the predictor was in the model. BMI
accounted for 16% of the variability in T-cell proliferation when
CD69 MFI on CD3+CD69+ T cells were included in the model
(Table S3 in Supplementary Material; R2= 15.79%). Dietary sele-
nium intake accounted for 10% of the variability in T-cell prolif-
eration when CD25 MFI on CD3+CD25+ T cells was included in
the model (Table S3 in Supplementary Material; R2= 10.30%).
The MFI of CD69 on unstimulated CD3+CD69+ T cells was
also significantly associated with IL-2 secretion from anti-CD3-
stimulated T cells. The MFI of CD69 on CD3+CD69+ T cells
accounted for 29% of the variability in IL-2 secretion (Table 3,
model 1, β= 0.0242, R2= 29.02%, p= 0.0010). When age, phys-
ical activity, daily total calories, vitamin D, and iron intake were
included in the model as confounding factors, 64% of the variabil-
ity in IL-2 secretion was explained (Table 3, model 2, β= 0.0205,
R2= 64.19%, p= 0.0002). The MFI of CD25 on unstimulated
CD3+CD25+ T cells was also significantly associated with IL-
2 secretion. The MFI of CD25 on freshly isolated, unstimulated
CD3+CD25+ T cells alone accounted for 55% of the variabil-
ity in IL-2 secretion (Table 3, model 1, β= 0.0276, R2= 55.29%,
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FIGURE 2 | Activation marker expression onT cells. Percentage of
CD3+CD69+ T cells (A) and CD3+CD25+ T cells (B) in total PBMCs, and
the MFI of CD69 on CD3+CD69+ T cells (C) and the MFI of CD25 on
CD3+CD25+ T cells (D) was assessed by flow cytometry. Data are
presented as mean±SEM. Bivariate plots of CD3 vs. CD69 expression
[(A) inset] or CD25 expression [(B) inset] from one representative subject
are shown. Insets of (C,D) show flow histograms of CD69 MFI on
CD3+CD69+ T cells and CD25 MFI on CD3+CD25+ cells from one
representative subject. Dashed lines represent isotype controls and solid
lines represent experimental samples.
p< 0.0001). After controlling for age, daily total calories, vita-
min D, and iron intake as confounding factors, the MFI of CD25
on unstimulated CD3+CD25+ T cells and confounding factors
accounted for 74% of the variability in IL-2 secretion (Table 3,
model 2, β= 0.0209, R2= 74.00%, p< 0.0001). Similar analyses
were done to explore the relationship between the MFI of CD69
and CD25 on unstimulated T-cell subsets and IL-2 secretion from
anti-CD3-stimulated T cells. Data are presented in Tables S1 and
S2 in Supplementary Material. The R2 of the predictor (activa-
tion marker expression) plus the individual confounding variables
included in the models described in Table 2 were examined to com-
pare the relative contribution of each confounding variable when
the predictor was in the model. None of the individual dietary or
lifestyle variables contributed more than 10% to variability in IL-2
secretion (Table S3 in Supplementary Material).
Unlike the relationship between T-cell activation marker
expression and IL-2 secretion, only the MFI of CD25 on unstim-
ulated CD3+CD25+ cells was associated with IFN-γ secretion
from anti-CD3-stimulated T cells. CD25 MFI on unstimulated
CD3+CD25+ cells alone accounted for 13% of the variability
in IFN-γ secretion (Table 3, model 1, β= 1.2020, R2= 12.91%,
p= 0.0369). However, the value of CD25 MFI on unstimulated
CD3+CD25+ cells was no longer significant when daily intake of
vitamin C, vitamin D, selenium, and n-3 PUFA were included in
the model as confounding variables (Table 3, model 2, β= 0.9655,
R2= 31.97%, p= 0.0958). CD69 MFI on CD3+CD69+ T cells
was not associated with IFN-γ secretion before (Table 3, model 1,
β= 0.9298, R2= 5.28, p= 0.1911) and after adjusting for con-
founding variables (Table 3, model 2, β= 0.7203, R2= 30.93,
p= 0.4823). Similar analyses were done to explore the relationship
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Table 2 | Contributions of individual variables to immune function and cold or flu incidence and severitya,b,c.
R2 (%) Odds ratio (95% CI) 95% CI
SI IL-2
secretion
IFN-γ
secretion
TNF-α
secretion
IL-6
secretion
Cold or flu incidence Number of days
with cold or flu
Age 1.38 10.25 2.69 0.01 0.35 1.085 (0.867, 1.359) (−0.105, 0.120)
BMI 0.72 0.39 2.70 2.81 0.16 1.085 (0.619, 1.901) (−0.258, 0.240)
Insulin 1.77 3.40 3.24 2.27 0.47 0.789 (0.546, 1.139) (−0.040, 0.191)
CRP 0.31 3.45 11.55 3.19 1.25 0.908 (0.683, 1.208) (−0.021, 0.098)
Serum total cholesterol 6.08 0.07 2.80 0.08 0.17 1.042 (0.989, 1.098) (−0.038, 0.002)
Serum HDL 0.00 10.98 0.15 1.36 1.55 0.950 (0.839, 1.076) (−0.042, 0.052)
PA 7.28 8.71 0.15 0.13 5.55 1.169 (0.141, 9.669) (−1.362, 1.275)
Dietary intake of
Total calories 0.00 3.33 0.02 16.68 9.89 0.998 (0.994, 1.002) (−0.001, 0.001)
Vitamin C 2.97 2.39 1.99 15.48 5.31 1.006 (0.982, 1.031) (−0.009, 0.014)
Vitamin D 1.98 11.27 12.13 8.05 4.67 1.002 (0.992, 1.012) (−0.321, 0.095)
Vitamin E 9.84 0.03 3.13 0.31 1.19 1.440 (0.894, 2.320) (−0.044, 0.013)
Iron 5.53 4.15 4.53 7.63 12.18 1.246 (0.726, 2.141) (−0.171, 0.103)
Selenium 2.49 5.07 3.23 0.28 2.93 1.047 (0.964, 1.137) (−0.044, 0.013)
Zinc 3.19 2.78 3.35 2.60 4.77 0.809 (0.364, 1.799) (−0.361, 0.214)
n-3 PUFA 1.81 0.41 1.44 0.47 5.80 0.013 (0.001, 5.176) (0.029, 2.920)
Caffeine 0.04 0.28 0.17 0.02 1.26 1.015 (0.992, 1.038) (−0.024, 0.005)
Alcohol consumption 0.55 0.01 1.16 1.87 2.73 1.039 (0.824, 1.311) (−0.085, 0.115)
aWaist circumference, glucose, SBP, and DBP were not included because they were collinear with BMI.
bSerum LDL and TG were not included because they were collinear with serum total cholesterol.
cDietary intake of carbohydrates, proteins, and fat were not included because they were collinear with total calorie intake.
Table 3 | Activation marker expression on unstimulated T cells as predictors of T-cell effector function.
CD69 MFI on CD3+CD69+ T cells CD25 MFI on CD3+CD25+ T cells
β R2 (%) Variables in the model p value β R2 (%) Variables in the model p value
Anti-CD3-induced T-cell proliferationa
Model 1 0.0058 29.17 CD69 MFI on CD3+CD69+ T cells 0.0008 0.0035 15.78 CD25 MFI on CD3+CD25+ T cells 0.0181
Model 2 0.0063 44.95 Model 1+BMI <0.0001 0.0021 36.29 Model 1+PA, vitamin D, selenium,
n-3 PUFA
0.1490
Anti-CD3-induced IL-2 secretion from T cells
Model 1 0.0242 29.02 CD69 MFI on CD3+CD69+ T cells 0.0010 0.0276 55.29 CD25 MFI on CD3+CD25+ T cells <0.0001
Model 2 0.0205 64.19 Model 1+ age, PA, total calories, vitamin
D, iron
0.0002 0.0209 74.00 Model 1+ age, PA, total calories,
vitamin D, iron
<0.0001
Anti-CD3-induced IFN-γ secretion from T cells
Model 1 0.9298 5.28 CD69 MFI on CD3+CD69+ T cells 0.1911 1.2020 12.91 CD25 MFI on CD3+CD25+ T cells 0.0369
Model 2 0.7203 30.93 Model 1+ age, BMI, PA, total calories,
vitamin C, D, selenium, zinc, alcohol
0.4823 0.9655 31.97 Model 1+ vitamin C, D, selenium,
n-3 PUFA
0.0958
aT-cell proliferation was evaluated by quantifying tritiated thymidine incorporation following stimulation with anti-CD3 antibodies, and results are reported as a stimulation
index. Stimulation index was calculated by dividing the cpm of the anti-CD3-induced T-cell proliferation by unstimulated T cells.
between the MFI of CD69 and CD25 on unstimulated T-cell sub-
sets and IFN-γ secretion from anti-CD3-stimulated T cells. Data
are presented in Tables S1 and S2 in Supplementary Material. Since
the MFI of CD69 and CD25 alone on T cells was not associ-
ated with IFN-γ secretion, we further examined the relationship
between IFN-γ secretion and other potential immunomodulatory
factors, including age, BMI, physical activity level, daily intake of
total calories, vitamin C, vitamin D, vitamin E, selenium, iron, zinc,
n-3 PUFA, caffeine, and alcohol consumption to determine which
variables significantly impacted IFN-γ secretion. Daily intake of
vitamin D was the only variable that was significantly associated
inversely with IFN-γ secretion. Vitamin D intake contributed to
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FIGURE 3 | LPS-stimulated IL-6 secretion from PBMCs,
anti-CD3-stimulated IFN-γ secretion fromT cells, and self-reported
cold or flu status in human subjects. IL-6 secretion from LPS-stimulated
PBMCs was significantly higher in subjects with self-reported cold or flu
symptoms compared to subjects without cold or flu symptoms
[(A); Mann–Whitney test, p= 0.0471]. IL-6 secretion was not correlated
with number of days with cold or flu symptoms [(C); Spearman r =0.2335,
p=0.2229]. IFN-γ secretion from anti-CD3-stimulated T cells in subjects
with cold or flu symptoms was significantly lower compared to subjects
without cold or flu symptoms [(B); unpaired t -test, p= 0.0376]. T-cell IFN-γ
secretion was inversely associated with total number of days with
self-reported cold or flu symptoms [(D); Spearman r =−0.4989,
p=0.0031]. Asterisk indicates a significant difference from no cold or flu
group (p< 0.05).
12% of the variability in IFN-γ secretion (Table 2, R2= 12.13; data
not shown, β=−88.4027, p= 0.0470).
CYTOKINE SECRETION AND HLA-DR EXPRESSION ON DCs AND
MACROPHAGES
The percentage of DCs (CD123+CD11c+HLA-DR+) and
macrophages (CD14+HLA-DR+) in PBMCs, and HLA-DR
expression on unstimulated DCs and macrophages were both
quantified. The percentage of DCs in PBMCs was 4.86± 1.12%
(range 0.07–14.18%) and the average MFI of HLA-DR on DCs
was 94,446± 10,084 (range 23,500–255,000; data not shown). The
percentage of macrophages in PBMCs was 14.38± 1.00% (range
3.79–27.22%) and the average MFI of HLA-DR on macrophages
was 46,817± 3528 (range 16,100–111,000; data not shown). TNF-
α and IL-6 secretion from PBMCs in response to 10µg/ml
LPS stimulation was also measured. The mean TNF-α and IL-6
production from LPS-stimulated PBMCs was 1.16± 0.10 ng/ml
(range 0.33–2.39 ng/ml) and 15.01± 1.15 ng/ml (range 5.55–
25.05 ng/ml), respectively. Of the variables shown in Table 1,
dietary iron contributed to 12.2% of the variability in IL-6
(Table 2; R2= 12.18%) and total calories and vitamin C con-
tributed to 16.7 and 15.5% of the variability in TNF-α secretion
(Table 2; R2= 16.68 and 15.48%, respectively). All other variables
contributed to less than 10% of the variability in IL-6 and TNF-α
secretion. HLA-DR expression on DCs and macrophages was not
associated with TNF-α and IL-6 production from LPS-stimulated
DCs and macrophages (data not shown).
CYTOKINE SECRETION WAS ASSOCIATED WITH THE INCIDENCE AND
SEVERITY OF COLD OR FLU SYMPTOMS
Participants (n= 34) completed a URTI questionnaire at their
clinical visit. According to their self-reported cold or flu inci-
dence, 17 participants had one or more cold or flu episodes in the
past month. The association between activation marker expression
(CD69 and CD25); T-cell proliferation; T-cell cytokine secre-
tion (IL-2 and IFN-γ); HLA-DR expression on antigen-presenting
cells; cytokine secretion (TNF-α and IL-6) from LPS-stimulated
PBMCs, and self-reported cold and flu incidence or severity was
examined by logistic and Poisson regression, respectively. No
association was observed between activation marker expression,
T-cell proliferation, HLA-DR expression on antigen-presenting
cells, and TNF-α secretion from LPS-stimulated PBMCs and cold
and flu incidence and severity (data not shown). However, IL-6
secretion from LPS-stimulated PBMCs was significantly higher
in participants with self-reported cold or flu symptoms com-
pared to participants without cold or flu symptoms in the past
month (Figure 3A, p= 0.0471). The average concentration of IL-
6 secretion from LPS-stimulated PBMCs of participants without
Frontiers in Immunology | Nutritional Immunology March 2015 | Volume 6 | Article 94 | 8
Meng et al. Cytokine production predicts cold/flu status
Table 4 | Cytokine secretion as predictors of self-reported cold or flu incidence and severity.
LPS-induced IL-6 secretion from PBMCs Anti-CD3-induced IFN-γ secretion fromT cells
β Odds ratio (95% CI) Variables in the model p value β Odds ratio (95% CI) Variables in the model p value
Incidence of cold or flu episode in the past montha,b
Model 1 −0.1471 0.863 (0.749, 0.994) IL-6 secretion 0.0414 0.0141 1.014 (0.997, 1.032) IFN-γ secretion 0.1019
Model 2 −0.2392 0.787 (0.632, 0.980) Model 1+ total calories,
vitamin C, iron, zinc
0.0325 0.0556 1.057 (0.986, 1.133) Model 1+ age, BMI,
vitamin D, iron, zinc, n-3
PUFA, alcohol, caffeine
0.1158
β 95% CI Variables in the model p value β 95% CI Variables in the model p value
Total number of days with cold or flu symptoms in the past monthc
Model 1 0.0252 −0.042, 0.092 IL-6 secretion 0.4609 −0.0138 −0.022, −0.006 IFN-γ secretion 0.0005
Model 2 0.0801 −0.018, 0.178 Model 1+ total calories,
iron, zinc
0.1105 −0.0153 −0.021, −0.009 Model 1+ vitamin C, zinc,
alcohol, caffeine
<0.0001
aLogistic regression model is fitted to determine the relationship between IL-6 or IFN-γ secretion and incidence of cold or flu in the past month.
bNo cold or flu episode in the past month= 0, presence of a cold or flu episode in the past month=1. Probability modeled is no cold or flu episode in the past month.
cPoisson regression model is fitted to determine the relationship between IL-6 or IFN-γ secretion and total number of days with cold or flu symptoms in the past
month.
self-reported cold or flu episodes was 12.17± 1.34 ng/ml and the
concentration of IL-6 secretion from participants with cold or
flu episodes was 17.00± 1.64 ng/ml. IL-6 secretion was associated
with the incidence of cold or flu episodes before [Table 4, model
1,β=−0.1471, odds ratio (OR)= 0.863, 95% CI= (0.749, 0.994),
p= 0.0414] and after incorporating daily intake of total calories,
vitamin C, iron, and zinc as confounding variables in the model
[Table 4, model 2, β=−0.2392, OR= 0.787, 95% CI= (0.632,
0.980), p= 0.0325]. However, IL-6 secretion was not associated
with the total number of days with self-reported cold or flu
symptoms before [Figure 3C, Spearman r = 0.2335, p= 0.2229;
and Table 4, model 1, β= 0.0252, 95% CI= (−0.042, 0.092),
p= 0.4609] and after incorporating daily intake of total calo-
ries, vitamin D, iron, and zinc as confounding variables in the
model [Table 4, model 2, β= 0.0801, 95% CI= (−0.018, 0.178),
p= 0.1105].
In contrast to IL-6 secretion, IFN-γ secretion from anti-CD3-
stimulated T cells was significantly lower in participants with
self-reported cold or flu symptoms compared to participants with-
out these symptoms in the past month (Figure 3B, p= 0.0376).
The average concentration of IFN-γ secretion from anti-CD3-
stimulated T cells of participants without self-reported cold or
flu episodes was 119.30± 10.45 ng/ml and the concentration of
IFN-γ secretion from participants with cold or flu episodes was
84.19± 12.45 ng/ml. IFN-γ secretion was not associated with the
self-reported incidence of cold or flu episodes alone [Table 4,
model 1, β= 0.0141, OR= 1.014, 95% CI= (0.997, 1.032),
p= 0.1019], or after incorporating confounding variables (age,
BMI, daily intake of vitamin D, iron, zinc, n-3 PUFA, caffeine, and
alcohol consumption) in the model [Table 4, model 2, β= 0.0556,
OR= 1.057, 95% CI= (0.983, 1.133), p= 0.1158]. However, IFN-
γ secretion was inversely correlated with total number of days
with self-reported cold or flu symptoms (Figure 3D, Spear-
man r =−0.4989, p= 0.0031). IFN-γ secretion was significantly
associated with total number of days with cold or flu symptoms
[Table 4, model 1, β=−0.0138, 95% CI= (−0.022, −0.006),
p= 0.0005]. After incorporating daily intake of vitamin C, zinc,
caffeine, and alcohol consumption as confounding variables in
the model, IFN-γ secretion was also significantly associated with
total number of days with cold or flu symptoms [Table 4, model 2,
β=−0.0153, 95% CI= (−0.021,−0.009), p< 0.0001]. The con-
tributions of the predictor (cytokine secretion) and individual
confounding variables in the regression models with cold or flu
incidence and severity as dependent variables are included as Table
S4 in Supplementary Material. Individual variables contributed a
small amount to the model (e.g., prediction of cold or flu incidence
or total number of days with cold symptoms). However, cytokine
secretion better predicted the incidence or severity of cold of flu
when dietary factors were included in the models.
DISCUSSION
To our knowledge, this study provides the first documentation that
expression of activation markers on freshly isolated, unstimulated
T cells is associated with effector function of activated T cells from
healthy human subjects. Flow cytometric analysis of CD69 and
CD25 expression on unstimulated T cells and T-cell subsets was
significantly correlated with anti-CD3-stimulated T-cell prolifera-
tive response and IL-2 secretion. However, neither CD69 nor CD25
expression was associated with IFN-γ secretion. These data sug-
gest that CD69 and CD25 expression on unstimulated T cells may
be a useful predictor of T-cell effector function following stimu-
lation. Furthermore, host factors (e.g., age, BMI, physical activity,
total calories, and select dietary factors) contribute significantly
to the relationship between activation marker expression and T-
cell effector function. Our study is also the first to demonstrate
that LPS-stimulated IL-6 secretion from PBMCs and anti-CD3-
induced IFN-γ secretion from T cells were significantly associated
with self-reported incidence and severity of cold or flu in the past
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month, respectively. These findings demonstrate the incidence and
severity of cold or flu symptoms captured via the URTI question-
naire were accompanied by relevant immunological changes. This
relationship was also strengthened by the inclusion of host factors
in the model. Collectively, these data suggest lifestyle and dietary
factors are important variables that contribute to the immune
response and should be included in human clinical trials assessing
immune endpoints.
Few clinical studies have examined T-cell proliferation and IL-
2 and IFN-γ secretion in response to anti-CD3 stimulation in
young healthy adults. Results from our study demonstrate that
among this population, T-cell effector function varied greatly, with
some individuals demonstrating robust T-cell effector responses,
and others not. To determine if these individuals with high T-
cell proliferation also had high cytokine secretion, we examined
the correlation between T-cell proliferation and IL-2 and IFN-γ
secretion. T-cell proliferation was significantly correlated with IL-2
secretion but not IFN-γ secretion. These results are not surprising
given the essentiality of IL-2 for T-cell proliferation (32). Previous
reports have demonstrated a positive association between IFN-γ
secretion and T-cell proliferation (33), however, in our popula-
tion, this was not the case. This may be due to the fact that PBMCs
rather than purified T cells were used in the IFN-γ secretion assay.
Although T cells are the major sources of IFN-γ secretion, the
secretion of IFN-γ by other immune cells (e.g., B cells, nature killer
cells) may minimize the association between IFN-γ secretion and
T-cell proliferation (34). The limited sample size (n= 36) in our
study may also partly explain the inconsistency between our results
and previous studies.
In addition to the heterogeneity in T-cell effector responses,
we observed that activation marker expression on T cells also var-
ied greatly among subjects. Stimulation of T cells by antigens or
mitogens induces upregulation of CD69 within 4 h, and CD25
between 24 and 48 h following T-cell activation, which in turn
triggers downstream signaling pathways that initiates prolifera-
tion and differentiation of T cells (32, 35–38). Several previous
studies have reported that CD69 or CD25 expression on antigen-
or mitogen-stimulated T cells is up-regulated in parallel with
T-cell proliferation (determined by [3H] thymidine incorpora-
tion) (39–41). However, these results are not consistent across
all studies (39–41). Results vary based on the different types of
stimuli (antigen or mitogen) and the length of the assay (39–41).
Simms et al. reported that anti-CD3 or staphylococcal entero-
toxin (SEB)-induced T-cell proliferation 72 h post stimulation is
correlated with the percentage of CD69+ T cells 24 h following
stimulation (39). Similar results are observed by Maino and col-
leagues, who found that the percentage of CD3+CD69+T cells
4 h post activation was correlated with PBMC proliferation fol-
lowing stimulation with anti-CD2 receptor antibodies for 72 h
(40). However, there was no correlation between the percentage
of CD69+ or CD25+ T cells and T-cell proliferation induced by
various other stimuli [phytohemagglutinin (PHA), SEB, tetanus
toxoid, or influenza A virus] for longer time periods (72, 120, 168,
and 168 h, respectively) (41). Thus, the nature of mitogenic or
antigenic stimuli and the time course of activation influence the
relationship between activation marker expression on T cells and
proliferative response of T cells. These studies suggest that quan-
tification of CD69 and CD25 expression on stimulated T cells may
not be a consistent marker of T-cell proliferative capacity because
the variability in assay conditions confounds this relationship.
To determine if the activation marker expression on freshly iso-
lated, unstimulated T cells was predictive of T-cell proliferation,
we used linear regression analyses using the expression of CD69
or CD25 (MFI of CD69 on CD3+CD69+ or MFI of CD25 on
CD3+CD25+) on unstimulated T cells as the independent vari-
able (predictor) and anti-CD3-induced T-cell proliferation as the
dependent variable (outcome). The MFI of CD69 on unstim-
ulated CD3+CD69+ T-cell contributed significantly (29.2%) to
the variability in T-cell proliferation (Table 3). To further explain
the heterogeneity in T-cell proliferation, we included other host
variables in the model that have previously been reported to mod-
ulate T-cell proliferation such as age, BMI, total calories, and select
dietary factors (5, 19, 20). The final model included both the MFI
of CD69 on CD3+CD69+ T cells and BMI, and these two variables
explained 45% of the variability in T-cell proliferation. Our data
demonstrate that CD69 MFI on unstimulated CD3+CD69+ T
cells was predictive of T-cell proliferation in response to anti-CD3
stimulation in young healthy adults. Numerous studies report a co-
stimulatory role of CD69 in T-cell proliferation (32, 35–38, 42).
Crosslinking CD69 with antibodies enhances human T-cell pro-
liferation induced by phorbol myristate acetate (PMA), PHA, or
anti-CD3 antibody (35–38, 42). Thus, baseline differences in CD69
expression may contribute to differences in T-cell proliferation via
varying amounts of co-stimulation. Moreover, we found that the
BMI of subjects contributed to the heterogeneity of T-cell prolif-
eration, and confounds the association between CD69 expression
and T-cell proliferation. Therefore, BMI should be quantified and
controlled for in studies quantifying T-cell proliferation.
The MFI of CD25 on unstimulated CD3+CD25+ T-cell also
contributed significantly (16%) to the variability in T-cell pro-
liferation (Table 3). These results are consistent with previous
studies which demonstrate a co-stimulatory role of CD25 in T-
cell proliferation (32). However, in our study, the MFI of CD25
on CD3+CD25+ T cells was no longer associated with T-cell pro-
liferation after incorporating physical activity and daily intake of
selenium, vitamin D, and n-3 PUFA as confounding variables in
our model (3, 18, 21–25). These data suggest that CD25 MFI
may only be marginally predictive of T-cell proliferation, but
other lifestyle and dietary patterns may contribute significantly
to T-cell proliferative responses. Similar analyses using activation
marker expression on unstimulated CD4+ and CD8+ T-cell sub-
sets as predictors find consistent results, which confirm our current
observations (Tables S1 and S2 in Supplementary Material).
Similar linear regression analyses were performed to explore
the association between CD69 and CD25 expression on unstimu-
lated T cells and anti-CD3-induced IL-2 secretion from T cells.
The MFI of CD69 on unstimulated CD3+CD69+ T-cell con-
tributed significantly (29%) to the variability in IL-2 secretion
(Table 3). To further explain the heterogeneity in IL-2 secretion
from activated T cells, we included several confounding variables
in the model that have previously been reported to modulate IL-2
secretion (3, 16, 18, 19, 21, 22, 26–31). The final model included
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both the MFI of CD69 on CD3+CD69+ T cells and age, physi-
cal activity, and daily intake of total calories, vitamin D, and iron.
Combined, these variables explained 64% of the variability in IL-2
secretion. Our observations are consistent with previous studies,
which report that crosslinking CD69 with anti-CD69 antibodies
enhance human IL-2 secretion following T-cell activation induced
by PMA, PHA, or anti-CD3 antibody (35–38, 42). However, our
findings are novel because we demonstrate that individual lifestyle
and dietary variables contribute a small amount to IL-2 secretion.
However, these variables significantly improved the predictive rela-
tionship between CD69 expression and IL-2 secretion suggesting
that host factors are important variables to quantify in clinical
studies assessing T-cell function.
Similarly, the MFI of CD25 on unstimulated CD3+CD25+
T-cell contributed significantly (55%) to the variability in IL-2
secretion (Table 3). In our final model, we controlled for age,
physical activity, and daily intake of total calories, vitamin D, and
iron, and the MFI of CD25 on unstimulated CD3+CD25+ T cells
and together these variables contributed significantly (74%) to
the variability in IL-2 secretion. Our findings are not surpris-
ing given the autocrine loop formed between CD25 expression
and IL-2 secretion during T-cell activation (32). Similar analy-
ses using activation marker expression on unstimulated CD4+
and CD8+ T-cell subsets as predictors found consistent results,
which confirmed our current observations (Tables S1 and S2 in
Supplementary Material). Our data suggest that the MFI of CD25
on unstimulated CD3+CD25+ T cells could serve as predictor of
IL-2 secretion from T cells in response to anti-CD3 stimulation
in young healthy adults. In addition, we found that host factors
including age, physical activity, daily intake of total calories, vita-
min D, and iron of subjects contributed to the association between
the MFI of CD25 on unstimulated CD3+CD25+ T cells and IL-2
secretion.
Unlike IL-2 secretion, we did not observe an association
between anti-CD3-induced IFN-γ secretion from T cells and the
MFI of CD69 on unstimulated CD3+CD69+ T cells either alone,
or after controlling for host factors that have previously been
reported to modulate T-cell IFN-γ secretion (22–25, 30, 31). How-
ever, the MFI of CD25 on unstimulated CD3+CD25+ T cells
contributed significantly (13%) to the variability in IFN-γ secre-
tion (Table 3). Previous studies demonstrate that the interaction
of IL-2 with CD25 (α chain of the IL-2 receptor) induces T cells to
secrete IFN-γ (32, 33). These data support the association between
MFI of CD25 alone and IFN-γ secretion. However, in our study the
association between CD25 MFI on unstimulated CD3+CD25+ T
cells and IFN-γ secretion was no longer significant after controlling
for daily intake of selenium, vitamin C, vitamin D, and n-3 PUFA
suggesting that these dietary factors significantly influence IFN-γ
response in human T cells (22–25, 30, 31). In fact, of the afore-
mentioned dietary variables, vitamin D intake contributed to 12%
of the variability in IFN-γ secretion, and daily intake of vitamin
D was inversely associated with IFN-γ secretion. This finding is in
agreement with previous studies, which report that vitamin D (25-
hydroxyvitamin D) and 1,25 dihydroxyvitamin D3, the active form
of vitamin D, inhibit IFN-γ secretion from mitogen-stimulated T
cells in humans and mice (24). Results from our study suggest that
activation marker expression (either CD69 or CD25) on freshly
isolated, unstimulated T cells was not strongly predictive of IFN-
γ secretion from activated T cells. Moreover, dietary and lifestyle
factors (in particular vitamin D status) contributed significantly to
the variability in IFN-γ secretion. Thus, the relationship between
dietary and lifestyle factors and IFN-γ secretion needs to be exam-
ined in a larger study to confirm these findings and to determine
the magnitude of the relationship. Similar analyses using activa-
tion marker expression on unstimulated CD4+ and CD8+ T-cell
subsets as predictors found consistent results (Tables S1 and S2 in
Supplementary Material).
To determine if the incidence and severity of cold or flu symp-
toms captured via the self-reported URTI questionnaire is accom-
panied by relevant immunological changes, we used two analytical
strategies. First, we performed logistic regression analysis using
IL-6 secretion from LPS-stimulated PBMCs as the independent
variable (predictor) and incidence of cold or flu episodes as the
dependent variable (outcome). Next, we ran Poisson regression
analysis using IL-6 secretion from LPS-stimulated PBMCs as the
independent variable (predictor) and total number of days with
cold or flu symptoms as the dependent variable (outcome). From
these two approaches, we found that IL-6 secretion was higher
in participants with self-reported cold or flu episodes compared
to participants without cold or flu episodes, and was significantly
associated with cold or flu incidence in the past month (Figure 3;
Table 4). IL-6 secretion remained significantly associated with
incidence of cold or flu after incorporating total calories, vita-
min C, iron, and zinc in the model (Table 4). However, we did
not observe an association between total number of days with
cold or flu symptoms and IL-6 secretion alone and with the addi-
tion of confounding variables (daily intake of total calories, iron,
and zinc). Our findings suggest that IL-6 secretion from LPS-
stimulated PBMCs was associated with the incidence of cold or flu
episodes, but was not related to the severity of cold or flu symp-
toms captured via self-reported URTI questionnaire. In addition,
we found that when dietary factors (total calories, vitamin C, iron,
and zinc) were included in the model, the association between IL-
6 secretion and the incidence of cold or flu symptoms in young
healthy adults was strengthened.
Previous studies report elevated levels of IL-6 during cold or
flu infection as a result of ongoing inflammation (43–45). The
release of IL-6 during cold or flu is also critical in coordinating the
innate and adaptive immune responses for efficient clearance of
infection (45). The heterogeneity in IL-6 secretion from PBMCs
in response to LPS stimulation may be attributable to genetic and
environmental factors (46, 47). Previous studies demonstrate an
association between polymorphisms in the gene encoding IL-6
(G/C polymorphism was detected at position-174) and secreted
level of IL-6 following stimulation. In particular, homozygos-
ity of IL-6-174C allele is associated with reduced transcription
and secretion of IL-6 in human plasma (48) and with decreased
frequency of the common cold (46). Therefore, the heterogene-
ity in LPS-stimulated IL-6 secretion from PBMCs observed in
our study may be due to polymorphisms in the gene encoding
IL-6, as well as environmental factors (e.g., BMI, dietary intake,
and physical activity), which contribute to the difference in IL-
6 secretion between participants with and without self-reported
cold or flu.
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Similar logistic and Poisson regression analyses were also per-
formed to determine if the incidence and severity of cold or flu
symptoms captured via the self-reported URTI questionnaire is
accompanied by IFN-γ secretion from anti-CD3-stimulated T
cells. The incidence of cold or flu was not associated with IFN-
γ secretion alone or following inclusion of age, BMI, daily intake
of vitamin D, iron, zinc, n-3 PUFA, caffeine, and alcohol con-
sumption in the model (Table 4). However, IFN-γ secretion from
anti-CD3-stimulated T cells was significantly associated with total
number of days with cold or flu symptoms alone and with the
addition of daily intake of vitamin C, zinc, caffeine, and alco-
hol consumption (Table 4). Our results suggest that the severity
but not the incidence of cold or flu symptoms assessed via the
self-reported URTI questionnaire was accompanied by changes
in IFN-γ secretion from anti-CD3-stimulated T cells in healthy
young adults. We also observed that the association between IFN-γ
secretion and severity of cold or flu symptoms was confounded by
daily intake of vitamin C, zinc, caffeine, and alcohol consumption,
suggesting that these dietary components impact this relationship.
Interferon-gamma production has been reported to play an
important role in the immune response against numerous viral
infections (47, 49). Thus, individuals who have lower IFN-γ pro-
duction may be more susceptible to infection with influenza virus
or rhinoviruses causing the common cold. The heterogeneity in
IFN-γ secretion following T-cell activation that we observed may
also be attributable to genetic and environmental factors (46, 47).
For example, a single nucleotide polymorphism (SNP) in IFN-γ
gene has been studied extensively and is presented as polymor-
phism +874 A/T. Results from a meta-analysis demonstrate that
the variant allele +874 A is correlated with lower levels of IFN-
γ production and increased risk of Mycobacterium tuberculosis
infection (50). It is plausible that individuals carrying the +874A
allele may be susceptible to other infections, including influenza
infection. Thus, IFN-γ gene polymorphisms may contribute to
the differences in IFN-γ secretion between individuals with and
without cold or flu episodes and the association between IFN-γ
secretion and incidence and severity of cold or flu symptoms in
our study. However, Becker et al. reported no association between
common cold frequency and CD2-induced IFN-γ secretion from
T cells in adults 45–65 years old (49). Previous studies demonstrate
an age-related reduction in the synthesis and secretion of IFN-γ
from PBMCs (26, 27). Thus, age may also impact the relationship
between cold and flu incidence and IFN-γ secretion.
In summary, we demonstrated that expression of CD69 and
CD25 expression on freshly isolated, unstimulated T cells was sig-
nificantly associated with anti-CD3-stimulated T-cell proliferation
and IL-2 secretion. We also found that IL-6 secretion from LPS-
stimulated PBMCs was associated with self-reported incidence of
cold or flu episodes, and IFN-γ secretion from T cells was asso-
ciated with self-reported severity of cold or flu symptoms in the
past month. Our data suggest that the incidence and severity of
cold or flu symptoms captured via the URTI questionnaire was
accompanied by relevant immunological changes. In addition, we
demonstrated that host-related factors, including age, BMI, phys-
ical activity, total calorie intake, and various dietary components
contributed to heterogeneity in T-cell function and incidence and
severity of cold or flu infection. These factors also confounded
the association between activation marker expression on T cells
and T-cell effector function, and the association between innate
and adaptive immune response and incidence and severity of
cold or flu symptoms. Therefore, quantification of dietary fac-
tors in human clinical trials measuring immune function may
be crucial to understanding the variability in immune responses
among subjects, and to determine the true relationship between
an intervention of interest and immune outcomes.
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